Heteroaryl Rheb inhibitors and uses thereof
US11339144B2 · kind B2 · utility
0Cited by
7References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2018 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Apr 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/0812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of general Formula I and I′: compositions thereof, and methods of using same to treat Rheb-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.